Past Issues

Proteomics Special- December-01, 2022

December-01

8

Worldwide Patients' Access to Life- Changing Therapies

Kinga Bercsenyi, PhD, European Lead for Precision Medicine & Biomarker Solutions, Cerba Research
18

Science-Led Data Collection: Because a Clinical Trial is Only as Good as Its Data

Lindsay Hughes, PhD, MS – Director, eCOA Science & Consulting Jowita Marszewska, PhD, eCOA Scientific Advisor
20

Partnering with a CDMO for successful late phase biologic drug product development and launch

Roman Mathaes, Head of Pharmaceutical Services, Cristina Grigore, Lonza
22

Cloud Computing Driving Change in Pharma Industry

Chris Braithwaite, SVP and Global Head of Drug Development Technology, Novartis
24

How Regulatory has become strategically important to food and feed companies

Caroline Herody, Head of Global Regulatory Affairs, Chr. Hansen
26

COVID-19 as a Catalyst for Digital Transformation of Clinical Research: Are we there yet?

Dr. Ammar Raza, Regional Medical Director- Middle East and Africa, Allergan Aesthetics, an AbbVie company
28

Beyond Industry 4.0: The Pharma Supply Chain of the Future

Mirko Senatore, Senior Director Global Supply Chain, Eastern Europe and Central Asia, Pfizer
30

Proteomics in Health Sciences

Philippe Pinton, SVP, Global Head Translational Medicine and Clinical Pharmacology, Ferring Pharmaceuticals

Biodesix, Inc. (NASDAQ: BDSX): The Market Leader In The Clinical Proteomics Field